Perineural invasion of hilar cholangiocarcinoma in Chinese population: One center's experience
- PMID: 32368323
- PMCID: PMC7191337
- DOI: 10.4251/wjgo.v12.i4.457
Perineural invasion of hilar cholangiocarcinoma in Chinese population: One center's experience
Abstract
Background: Hilar cholangiocarcinoma (HCCA) often produces perineural invasion (PNI) extending to extra-biliary sites, while significant confusion in the incidence of PNI in HCCA has occurred in the literature, and the mechanism of that procedure remains unclear.
Aim: To summarize the incidence of PNI in HCCA and to provide the distribution of nerve plexuses around hepatic portal to clinical surgeons.
Methods: Reported series with PNI in HCCA since 1996 were reviewed. A clinicopathological study was conducted on sections from 75 patients with HCCA to summarize the incidence and modes of PNI. Immunohistochemical stains for CD34 and D2-40 in the cancer tissue were performed to clarify the association of PNI with microvessel and lymph duct. Sections of the hepatoduodenal ligament from autopsy cases were scanned and handled by computer to display the distribution of nerve plexuses around the hepatic portal.
Results: The overall incidence of PNI in this study was 92% (69 of 75 patients), while the rate of PNI in HCCA in the literature ranging from 38% to 100%. The incidence of PNI did not show any remarkable differences among various differentiated groups and Bismuth-Corlette classification groups. Logistic regression analysis identified the depth of tumor invasion was the only factor that correlated significantly with PNI (P < 0.01). In spite of finding tumor cells that could invade microvessels and lymph ducts in HCCA, we did not find tumor cells invaded nerves via microvessels or lymph ducts. Three nerve plexuses in the hepatoduodenal ligament and Glisson's sheath were classified, and they all surrounded the great vessels very closely.
Conclusion: The incidence of PNI of HCCA in Chinese population is around 92% and correlated significantly with a depth of tumor invasion. It also should be considered when stratifying HCCA patients for further treatment.
Keywords: Hilar cholangiocarcinoma; Incidence; Nerve plexus; Pathology; Perineural invasion; Treatment.
©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: The authors have no conflicts of interest to declare.
Figures
Similar articles
-
Characteristic of Perineural Invasion in Hilar Cholangiocarcinoma Based on Whole-Mount Histologic Large Sections of Liver.Front Oncol. 2022 Mar 8;12:855615. doi: 10.3389/fonc.2022.855615. eCollection 2022. Front Oncol. 2022. PMID: 35350570 Free PMC article.
-
[Perineural invasion in hilar cholangiocarcinoma and distribution of nerve plexuses around porta hepatis].Zhonghua Yi Xue Za Zhi. 2012 Oct 16;92(38):2699-702. Zhonghua Yi Xue Za Zhi. 2012. PMID: 23290109 Chinese.
-
Preliminary study of perineural invasion in patients with hilar cholangiocarcinoma by computed tomography imaging.Clin Imaging. 2020 May;61:49-53. doi: 10.1016/j.clinimag.2019.12.020. Epub 2020 Jan 7. Clin Imaging. 2020. PMID: 31954352
-
Combined portal vein resection in the treatment of hilar cholangiocarcinoma: a systematic review and meta-analysis.Eur J Surg Oncol. 2014 May;40(5):489-495. doi: 10.1016/j.ejso.2014.02.231. Epub 2014 Feb 28. Eur J Surg Oncol. 2014. PMID: 24685155 Review.
-
Minimally invasive surgery for hilar cholangiocarcinoma: state of art and future perspectives.ANZ J Surg. 2019 May;89(5):476-480. doi: 10.1111/ans.14765. Epub 2018 Aug 22. ANZ J Surg. 2019. PMID: 30136376 Review.
Cited by
-
CT-Based Radiomics Analysis for Noninvasive Prediction of Perineural Invasion of Perihilar Cholangiocarcinoma.Front Oncol. 2022 Jun 20;12:900478. doi: 10.3389/fonc.2022.900478. eCollection 2022. Front Oncol. 2022. PMID: 35795043 Free PMC article.
-
Characteristic of Perineural Invasion in Hilar Cholangiocarcinoma Based on Whole-Mount Histologic Large Sections of Liver.Front Oncol. 2022 Mar 8;12:855615. doi: 10.3389/fonc.2022.855615. eCollection 2022. Front Oncol. 2022. PMID: 35350570 Free PMC article.
References
-
- Kovalenko YA, Zharikov YO, Kukeev IA, Vishnevsky VA, Chzhao AV. [Predictors of outcomes in surgery for hilar cholangiocarcinoma] Khirurgiia (Mosk) 2018:5–11. - PubMed
-
- Bird NTE, McKenna A, Dodd J, Poston G, Jones R, Malik H. Meta-analysis of prognostic factors for overall survival in patients with resected hilar cholangiocarcinoma. Br J Surg. 2018;105:1408–1416. - PubMed
-
- Ercolani G, Zanello M, Grazi GL, Cescon M, Ravaioli M, Del Gaudio M, Vetrone G, Cucchetti A, Brandi G, Ramacciato G, Pinna AD. Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center. J Hepatobiliary Pancreat Sci. 2010;17:329–337. - PubMed
-
- Young AL, Prasad KR, Toogood GJ, Lodge JP. Surgical treatment of hilar cholangiocarcinoma in a new era: comparison among leading Eastern and Western centers, Leeds. J Hepatobiliary Pancreat Sci. 2010;17:497–504. - PubMed
LinkOut - more resources
Full Text Sources
